Testosterone inhibits transforming growth factor-β signaling during myogenic differentiation and proliferation of mouse satellite cells: Potential role of follistatin in mediating testosterone action
- 1 March 2012
- journal article
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 350 (1) , 39-52
- https://doi.org/10.1016/j.mce.2011.11.019
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Aging (SC1AG033407)
This publication has 35 references indexed in Scilit:
- Follistatin Improves Skeletal Muscle Healing after Injury and Disease through an Interaction with Muscle Regeneration, Angiogenesis, and FibrosisThe American Journal of Pathology, 2011
- Reduced SMAD7 Leads to Overactivation of TGF-β Signaling in MDS that Can Be Reversed by a Specific Inhibitor of TGF-β Receptor I KinaseCancer Research, 2011
- BMP signalling permits population expansion by preventing premature myogenic differentiation in muscle satellite cellsCell Death & Differentiation, 2010
- Relative roles of TGF‐β1 and Wnt in the systemic regulation and aging of satellite cell responsesAging Cell, 2009
- Testosterone and Growth Hormone Improve Body Composition and Muscle Performance in Older MenJournal of Clinical Endocrinology & Metabolism, 2009
- Inhibition of myostatin with emphasis on follistatin as a therapy for muscle diseaseMuscle & Nerve, 2009
- Regulation of Myogenic Differentiation by Androgens: Cross Talk between Androgen Receptor/ β-Catenin and Follistatin/Transforming Growth Factor-β Signaling PathwaysEndocrinology, 2008
- Myostatin promotes a fibrotic phenotypic switch in multipotent C3H 10T1/2 cells without affecting their differentiation into myofibroblastsJournal of Endocrinology, 2007
- Smad-Sp1 complexes mediate TGF -induced early transcription of oncogenic Smad7 in pancreatic cancer cellsCarcinogenesis: Integrative Cancer Research, 2006
- The Effects of Supraphysiologic Doses of Testosterone on Muscle Size and Strength in Normal MenNew England Journal of Medicine, 1996